Clustered patterns of species origins of nature-derived drugs and clues for future bioprospecting.
about
Traditional medicines and globalization: current and future perspectives in ethnopharmacologyCan phylogeny predict chemical diversity and potential medicinal activity of plants? A case study of AmaryllidaceaeGenomics and Evolution in Traditional Medicinal Plants: Road to a Healthier Life.Drug discovery prospect from untapped species: indications from approved natural product drugsWhat does it take to synergistically combine sub-potent natural products into drug-level potent combinations?An Improved Method for P2X7R Antagonist ScreeningEvolutionary history and leaf succulence as explanations for medicinal use in aloes and the global popularity of Aloe veraPerformance Evaluation and Online Realization of Data-driven Normalization Methods Used in LC/MS based Untargeted Metabolomics Analysis.Microbial genome mining for accelerated natural products discovery: is a renaissance in the making?Configurational assignments of conformationally restricted bis-monoterpene hydroquinones: utility in exploration of endangered plants.The first cyclomegastigmane rhododendroside A from Rhododendron brachycarpum alleviates HMGB1-induced sepsis.Phylogenies reveal predictive power of traditional medicine in bioprospecting.NOREVA: normalization and evaluation of MS-based metabolomics data.Leveraging biodiversity knowledge for potential phyto-therapeutic applicationsSignificance of endangered and threatened plant natural products in the control of human disease.Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery.CancerHSP: anticancer herbs database of systems pharmacology.Statistical Correlations between HPLC Activity-Based Profiling Results and NMR/MS Microfraction Data to Deconvolute Bioactive Compounds in Mixtures.Exploiting a precise design of universal synthetic modular regulatory elements to unlock the microbial natural products in Streptomyces.Sequestered defensive toxins in tetrapod vertebrates: principles, patterns, and prospects for future studiesPhylogeny Predicts the Quantity of Antimalarial Alkaloids within the Iconic Yellow Cinchona Bark (Rubiaceae: Cinchona calisaya).Evolutionary prediction of medicinal properties in the genus Euphorbia L.Genomes to hits in silico - a country path today, a highway tomorrow: a case study of chikungunya.Phylogenetic Tree Analysis of the Cold-Hot Nature of Traditional Chinese Marine Medicine for Possible Anticancer Activity.Therapeutic target database update 2014: a resource for targeted therapeutics.Clustered distribution of natural product leads of drugs in the chemical space as influenced by the privileged target-sites.Potassium channels: structures, diseases, and modulators.Natural products in soil microbe interactions and evolution.Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products.Prospecting for new bacterial metabolites: a glossary of approaches for inducing, activating and upregulating the biosynthesis of bacterial cryptic or silent natural products.Natural products for human health: an historical overview of the drug discovery approaches.In vitro and in silico evaluation of NF-κB targeted costunolide action on estrogen receptor-negative breast cancer cells--a comparison with normal breast cells.Natural products, their derivatives, mimics and synthetic equivalents: role in agrochemical discovery.Antimicrobial, Anthelmintic, and Antiviral Activity of Plants Traditionally Used for Treating Infectious Disease in the Similipal Biosphere Reserve, Odisha, India.NPASS: natural product activity and species source database for natural product research, discovery and tool development.An improved approach for predicting drug-target interaction: proteochemometrics to molecular docking.Phylogenetic exploration of commonly used medicinal plants in South Africa.Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics.Assessing the Performances of Protein Function Prediction Algorithms from the Perspectives of Identification Accuracy and False Discovery Rate.Revealing vilazodone's binding mechanism underlying its partial agonism to the 5-HT1A receptor in the treatment of major depressive disorder.
P2860
Q21129278-E672D493-4FDC-46ED-B57E-1151745E58CDQ21284032-DF12414E-02CC-43BC-B16C-79EEC8AEB5B3Q26783752-E392597C-452F-42D6-ABD4-7A945355D991Q28481257-27F3337B-FDA6-4F30-B982-45E7A0D98200Q28485360-87C86CF2-4A93-41E1-96BB-8C108188E2F4Q28547334-F4ED1970-1792-4CB5-AB64-141EA799F2CBQ28649342-12A54005-8CD2-46B8-A3DF-75E8E50694BBQ31148475-86CE51ED-D6B5-4893-8030-BAE7B1716925Q33804081-8EB4121B-6FD1-4038-9699-4DCBD96C166AQ34072859-B4563114-519F-4451-9983-9B9CC3CA9F2BQ34111999-C5997D25-12DA-446D-8B52-AD63612A75BEQ34415770-1DF968A6-7277-4978-98F9-1F4E7FABCE1DQ34556970-EDFD3BA8-47D6-4334-8D4C-401615DBC7D2Q34631299-F415ECEB-FEE1-4ABD-BB15-E4D20898E8ABQ35003143-9A55D623-E9D0-4DA9-864D-DE4E1D22B986Q35631111-7FE4065B-C77D-4573-917C-DF601F7BDA2CQ35740846-8597C6EA-57C5-4111-B86F-51BF0B9A37BFQ35939772-425C9706-7C27-4A73-B7EF-B27FD79A6ACDQ36120216-60602B13-8991-4E5C-8A32-FC2B12C64858Q36162358-F237B6ED-1524-43FA-A573-C409CDFA7AA3Q36337440-AE264F49-49CF-4646-90C8-35D0842A8895Q37134190-CFEBE050-EFD0-4227-850D-502CB75DBE82Q37319331-56873605-4783-44D0-B9B2-C375A48213ACQ37612730-C29252B5-24B7-410D-BD10-B056BE9925A6Q37661746-1AFA1CFB-9684-4B4E-9E00-D2DF4E815977Q37737158-D8A0B239-1B37-499A-B53B-626F94CB0E81Q38151974-B0F0DA2B-EAF5-4E65-9495-79BD01FF77BAQ38497922-725FBED3-E094-46C0-BB87-20813A7A297CQ38510631-E926E162-9E94-47C7-9101-24F9FF201124Q38625630-A1A946A5-7B7D-4ECE-AAAB-A18D6E545171Q38651171-70786248-E13D-4BE1-8B0F-300A8246D4BFQ39004090-718E9F69-6A9C-4A73-B18C-C6ECF5936809Q39292924-B2208EE0-7750-4617-BC42-57BB4DABB9B8Q46267394-4B031E67-8252-42BE-AE67-1E891A634915Q46268156-12A37842-EFFA-4E72-91B7-D9580AFC7B6AQ46603422-D4885377-6962-4013-AAB8-CD5D8B08131CQ46749346-21114061-CC1A-4BC6-B9C6-AE27473F199FQ47116549-0F25A80B-A019-41C2-B4AF-C028EEAB7E55Q47216858-D2AE6C09-8D5F-48A9-A95D-5D1FE4BCAD47Q47732078-44C06C8C-DF60-4FB1-B29A-6BAB7C916AEA
P2860
Clustered patterns of species origins of nature-derived drugs and clues for future bioprospecting.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Clustered patterns of species ...... ues for future bioprospecting.
@ast
Clustered patterns of species ...... ues for future bioprospecting.
@en
type
label
Clustered patterns of species ...... ues for future bioprospecting.
@ast
Clustered patterns of species ...... ues for future bioprospecting.
@en
prefLabel
Clustered patterns of species ...... ues for future bioprospecting.
@ast
Clustered patterns of species ...... ues for future bioprospecting.
@en
P2093
P2860
P356
P1476
Clustered patterns of species ...... ues for future bioprospecting.
@en
P2093
Chunyan Tan
Jinshun Lin
Xiaohua Ma
P2860
P304
12943-12948
P356
10.1073/PNAS.1107336108
P407
P577
2011-07-18T00:00:00Z